LEADER 01352nam  2200421   450 
001 9910815145203321
005 20230807213410.0
010   $a92-0-118619-3
035   $a(CKB)3710000001364560
035   $a(MiAaPQ)EBC4853269
035   $a(EXLCZ)993710000001364560
100   $a20170602h20152015  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 14$aThe transition from 2-D brachytherapy to 3-D high dose rate brachytherapy /$fInternational Atomic Energy Agency
210  1$aVienna, [Austria] :$cInternational Atomic Energy Agency,$d2015.
210  4$dİ2015
215   $a1 online resource (47 pages) $ccolor illustrations
225 1 $aIAEA Human Health Reports,$x2074-7667 ;$vNumber 12
311   $a92-0-101415-5 
410  0$aIAEA human health reports ;$vNumber 12.
606   $aRadioisotope brachytherapy
606   $aCancer$xRadiotherapy
606   $aRadiotherapy
615  0$aRadioisotope brachytherapy.
615  0$aCancer$xRadiotherapy.
615  0$aRadiotherapy.
676   $a615.8424
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910815145203321
996   $aThe transition from 2-D brachytherapy to 3-D high dose rate brachytherapy$93925776
997   $aUNINA